Explore
Companies
Investors
Top 50
Streams
Trending tech news
Latest investments
Latest acquisitions
Products
Automate
Trackers
Innovation Services
About Index
Index
By TNW
Log in
Register
Paradigm Diagnostics
3152
Paradigm Diagnostics
Technology
Biotechnology
Paradigm is a non-profit corporation established to bring cutting-edge diagnostics and biomarker driven clinical trials to benefit cancer patients.
Suggest edits
Raised
$8.9M
Follow us
Companies in the same industry
Acticor Biotech
RegeneRx
Tricida, Inc.
microDimensions
ONL Therapeutics
Avelas Biosciences
Tioma Therapeutics
ActnerLab
Proclara Biosciences
Peloton Therapeutics
Alexa global traffic share
Twitter followers
Overview
Funding
1
Add info
Latest funding
$8,929,993
Venture capital (Series B) - 2018
New Science Ventures
Mesa Verde Venture Partners
Team Size
1–10
Employees
I work here
Location
United States
Headquarters
Explore United States
$8,929,993
Venture capital (Series B)
FinSMEs
Paradigm Diagnostics Raises $7M in First Close of Series B Funding
TechCrunch
Paradigm CEO Joelle Emerson On Why Talk Of “Lowering The Bar” Is Inherently Racist
TechCrunch
Pinterest Is Working With A Startup Called Paradigm To Foster Diversity
Diversity
Employment
